MedTrace Logo

Implementation of a Social and Mental Health Support to Promote Recovery in Five Mental Health Facilities in Paris Area

NCT05274126 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-03-25

No results posted yet for this study

Summary

Prospective longitudinal uncontrolled multicenter study, with cohort follow-up, focusing on patients, professionals, relatives and structures evolution during the implementation of recovery based intervention.

Conditions

  • Severe Mental Disorder

Interventions

BEHAVIORAL

Patient group/Passvers

Passvers intervention aims at : * helping patients followed in the centers, presenting a Severe and Persistent Mental Disorder (schizophrenia, mood disorder, autism spectrum disorder, etc.), at risk or in a situation of psychological disability, to enroll in a rehabilitation program towards recovery. * supporting the emergence and construction of projects by the people themselves, and to accompany them to realize them. * Encouraging the use of resources in their environment and common law mechanisms (city hall, department, associations, etc.) for better social integration. * encouraging involvement in care understood as useful tools for the realization of the personal project. Passvers also aims at : * promoting a change in professional practices within the team, in favor of recovery-oriented practices based on the concept of engagement or empowerment. * allowing cooperation between health and social structures aiming at destigmatizing mental illness.

Sponsors & Collaborators

  • Agence régionale de santé Ile de France

    collaborator UNKNOWN

  • UNION NATIONALE DE FAMILLES ET AMIS DE PERSONNES MALADES ET/OU HANDICAPÉES PSYCHIQUES

    collaborator UNKNOWN

  • Versailles Hospital

    lead OTHER

Principal Investigators

  • Christine Passerieux, Prof · CH Versailles

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2025-05-01
Completion
2026-05-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274126 on ClinicalTrials.gov